In the latest trading session, 0.69 million Wave Life Sciences Ltd (NASDAQ:WVE) shares changed hands as the company’s beta touched -1.20. With the company’s most recent per share price at $16.40 changed hands at -$0.04 or -0.24% at last look, the market valuation stands at $2.54B. WVE’s current price is a discount, trading about -2.07% off its 52-week high of $16.74. The share price had its 52-week low at $3.50, which suggests the last value was 78.66% up since then. When we look at Wave Life Sciences Ltd’s average trading volume, we note the 10-day average is 1.3 million shares, with the 3-month average coming to 1.69 million.
Analysts gave the Wave Life Sciences Ltd (WVE) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.20. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended WVE as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Wave Life Sciences Ltd’s EPS for the current quarter is expected to be -0.28.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wave Life Sciences Ltd (NASDAQ:WVE) trade information
Instantly WVE was in red as seen in intraday trades today. With action 18.50%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 224.75%, with the 5-day performance at 18.50% in the green. However, in the 30-day time frame, Wave Life Sciences Ltd (NASDAQ:WVE) is 87.86% up. Looking at the short shares, we see there were 4.89 million shares sold at short interest cover period of 2.04 days.
The consensus price target for the stock as assigned by Wall Street analysts is 19, meaning bulls need an upside of 13.68% from its recent market value. According to analyst projections, WVE’s forecast low is 15 with 22 as the target high. To hit the forecast high, the stock’s price needs a -34.15% plunge from its current level, while the stock would need to tank 8.54% for it to hit the projected low.
Wave Life Sciences Ltd (WVE) estimates and forecasts
Data shows that the Wave Life Sciences Ltd share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 180.82% over the past 6 months, a -87.04% in annual growth rate that is considerably lower than the industry average of 17.10%. Year-over-year growth is forecast to reach -38.40% down from the last financial year.
Consensus estimates given by 10 financial analysts project the company’s revenue in the current quarter to hit an average of 16.95M. 10 analysts are of the opinion that Wave Life Sciences Ltd’s revenue for the current quarter will be 20.64M. The company’s revenue for the corresponding quarters a year ago was 49.21M and 29.06M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -65.60%. The estimates for the next quarter sales put growth at -29.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 36.03%. The 2024 estimates are for Wave Life Sciences Ltd earnings to decrease by -87.71%.
WVE Dividends
Wave Life Sciences Ltd is expected to release its next quarterly earnings report on 2024-Nov-12.
Wave Life Sciences Ltd (NASDAQ:WVE)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 15.79% of Wave Life Sciences Ltd shares while 66.20% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 78.61%. There are 66.20% institutions holding the Wave Life Sciences Ltd stock share, with RA CAPITAL MANAGEMENT, L.P. the top institutional holder. As of 2024-06-30, the company held 14.0527% of the shares, roughly 18.2 million WVE shares worth $90.83 million.
MAVERICK CAPITAL LTD holds the second largest percentage of outstanding shares, with 5.9211% or 7.67 million shares worth $38.27 million as of 2024-06-30.
